American Medical Technologies (North American) Ltd.
American Medical Technologies (North American) Ltd. (Trading as M20 on the Frankfurt exchange)
American Medical Technologies (North American) Ltd. / Miscellaneous Release of a Corporate News, transmitted by DGAP - a company of EquityStory AG. The issuer / publisher is solely responsible for the content of this announcement. ---------------------------------------------------------------------- Toronto - American Medical Technologies (North American) Ltd. (Trading as M20 on the Frankfurt exchange). American Medical Technologies announced today that proprietary Blood Cell Morphometric Method (BCMM) technology was examined using Directed Evolution Method (Ideation International, Inc.) that provides means not only to predict but to direct future technological achievements in a given time frame with a specified level of support. With hindsight, what seems obscure today will be remarkably clear tomorrow. The role of Directed Evolution is to evaluate today's knowledge systematically, thereby identifying what is achievable and, more particularly, how one technological advance, perhaps in conjunction with another, could fulfill a human need. Blood Cell Morphometric Method that allows to properly predict the direction of the research to substantially cut time and simplify the logistics for the final stages of project completion. According to Dr. Farber, with our unique Blood Cell Morphometric Method, we will be able to provide new and effective technology to deal with early cancer detection in healthy individuals and monitor the treatment efficiency in patients diagnosed with cancer. This might become a new standard of care and revolutionize the field of multibillion oncology market. The analysis showed that there are other earlier unknown directions for our BCMM development that can result in further perfection of our existing technology that may allow American Medical Technologies to complete automated analysis much faster and significantly cut the time to commercial use. For further information contact: CONTACT: Dr. Boris Farber American Medical Technologies (North American) Ltd. 550 Ocean Parkway Brooklyn, NY 11218 Phone: 347-533-4349 Fax: 347-533-4350 bfarber@americanmedtec.com 18.05.2009 Financial News transmitted by DGAP ----------------------------------------------------------------------
Latest News
Latest Reports
No Reports found
Upcoming Events
No Events found
Webcasts
No Webcasts found